Related Experiment Video
Updated: Sep 19, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Using radiomics model for predicting extraprostatic extension with PSMA PET/CT studies: a comparative study with the
Linjie Bian1,2,3,4,5,6, Fanxuan Liu7, Yige Peng7
1Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
A new radiomics model using PSMA PET/CT effectively predicts extraprostatic extension (EPE) in prostate cancer, outperforming the MRI-based Mehralivand Grading System. Further validation is needed for clinical use.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Extraprostatic extension (EPE) is a critical factor in prostate cancer staging and treatment planning.
- Accurate preoperative assessment of EPE is essential for guiding surgical and therapeutic decisions.
Purpose of the Study:
- To evaluate a radiomics model for predicting EPE in prostate cancer using PSMA PET/CT imaging.
- To compare the predictive performance of the radiomics model against the Mehralivand Grading System, an MRI-based assessment tool.
Main Methods:
- Radiomics features were extracted from PSMA PET/CT images of 206 patients undergoing radical prostatectomy.
- Predictive models were developed using Support Vector Machine and Random Forest algorithms.
- Performance was compared to the Mehralivand Grading System in 63 patients with both PSMA PET/CT and mpMRI.
Main Results:
- The PSMA PET/CT radiomics model achieved an AUC of 76.8%, outperforming the Mehralivand Grading System (AUCs ranging from 60.2% to 66.8%).
- The radiomics model demonstrated superior sensitivity (72.0%) and specificity (81.5%) compared to the grading system.
- Statistical analysis confirmed the radiomics model's significant outperformance over all readers of the Mehralivand Grading System (p < 0.013).
Conclusions:
- The radiomics model derived from PSMA PET/CT shows significant promise for improving preoperative EPE assessment in prostate cancer.
- This AI-driven approach may enhance the accuracy of predicting EPE compared to current MRI-based methods.
- Further validation in larger, independent cohorts is recommended to establish clinical utility.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022